Review and comparison of clinical evidence submitted to support European Medicines Agency market authorization of orphan-designated oncological treatments. [electronic resource]
- Orphanet journal of rare diseases Oct 2015
- 139 p. digital
Animals Antineoplastic Agents--economics Clinical Trials as Topic--economics Drug Approval--economics Europe Humans Orphan Drug Production--economics Rare Diseases--drug therapy